Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | FABP3 | P05413 | 2/20 | 0.41 |
| ▸ | FABP4 | P15090 | 2/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2050376 | 0.94 | GABRA1 (0.48) | BACE1GABRA1GABRB2ADRB2HIF1A | |
| SCHEMBL28900423 | 0.91 | GABRA1 (0.46) | BACE1GABRA1GABRB2ADRB2HIF1A | |
| SCHEMBL16528520 | 0.86 | CA1 (0.44) | BACE1GABRA1GABRB2ADRB2HIF1A | |
| SCHEMBL487239 | 0.84 | ALDH1A1 (0.57) | BACE1GABRA1GABRB2ADRB2HIF1A | |
| SCHEMBL30345322 | 0.84 | ALDH1A1 (0.57) | BACE1GABRA1GABRB2ADRB2HIF1A | |
| SCHEMBL10931556 | 0.82 | ALDH1A1 (0.43) | GABRA1GABRB2ADRB2HIF1ATSHR | |
| SCHEMBL20483093 | 0.82 | GABRA1 (0.48) | BACE1GABRA1GABRB2ADRB2HIF1A | |
| SCHEMBL681628 | 0.82 | CA1 (0.55) | BACE1GABRA1GABRB2ADRB2HIF1A | |
| SCHEMBL13523275 | 0.82 | GABRA1 (0.48) | GABRA1GABRB2ADRB2HIF1ATSHR | |
| SCHEMBL27533810 | 0.82 | ALDH1A1 (0.55) | GABRA1GABRB2ADRB2HIF1ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4376854-A | Process for preparing resorcinol copolymers | HODOGAYA CHEMICAL CO., LTD. (JP) | 1983-03-15 | — | — | US | claimed |
| JP-56110930-A | — | — | None | — | — | JP | disclosed |
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |
| US-11858917-B2 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus | YALE UNIVERSITY (US) | 2024-01-02 | — | — | US | disclosed |
| US-20220133634-A1 | SUSTAINED RELEASE SOLID DOSAGE FORMS FOR MODULATING THE COLONIC MICROBIOME | AXIAL THERAPEUTICS, INC. (US) | 2022-05-05 | — | — | US | disclosed |
| CN-114008010-A | Isolation of bisphenol A by depolymerization of poly (carbonate) | 高新特殊工程塑料全球技术有限公司 | 2022-02-01 | — | — | CN | disclosed |
| US-11129781-B2 | Agent for hair deforming treatment | KAO CORPORATION (JP) | 2021-09-28 | — | — | US | disclosed |
| US-20210198223-A1 | METHODS AND COMPOSITIONS RELATING TO ULTRAPURE 5-(1,1-DIMETHYLHEPTYL)-RESORCINOL | CORBUS PHARMACEUTICALS, INC. | 2021-07-01 | — | — | US | disclosed |
| US-11045402-B2 | Hair cosmetic composition | KAO CORPORATION (JP) | 2021-06-29 | — | — | US | disclosed |
| US-20210163387-A1 | ONE-STEP FLOW-MEDIATED SYNTHESIS OF CANNABIDIOL (CBD) AND DERIVATIVES | TRUSTEES OF BOSTON UNIVERSITY (US) | 2021-06-03 | — | — | US | disclosed |
| JP-S56110930-A | DIAZO TYPE COPYING MATERIAL | TAOKA CHEM CO LTD | 1981-09-02 | — | — | JP | disclosed |
| US-4251640-A | OF AN UNSATURATED POLYESTER CONTAINING A PEROXIDE INITIATOR AND A PROMOTER | AKZONA INCORPORATED (US) | 1981-02-17 | — | — | US | disclosed |
| US-4202833-A | INTERMEDIATES TO BISPHENOL CARBONATES | THE UPJOHN COMPANY (US) | 1980-05-13 | — | — | US | disclosed |
| US-4200763-A | CHEMICAL INTERMEDIATE | THE UPJOHN COMPANY (US) | 1980-04-29 | — | — | US | disclosed |
| US-4180669-A | ANTISECRETORY AGENTS | ABBOTT LABORATORIES (US) | 1979-12-25 | — | — | US | disclosed |
| US-4164510-A | METAL PHTHALOCYANINE, TERT-ALKYL PEROXIDE AS CATALYST | THE UPJOHN COMPANY (US) | 1979-08-14 | — | — | US | disclosed |
| US-4129413-A | Oxidation hair dyes based upon tetraaminopyrimidine developers and mono- and dialkyl -m- dihydroxy benzene couplers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 1978-12-12 | — | — | US | disclosed |
| US-4123461-A | Benzene-tricarboxylic acid-(1,3,5)-tri-N-chloramide and process for the preparation thereof | AKZONA INCORPORATED (US) | 1978-10-31 | — | — | US | disclosed |
| US-4057588-A | Process for the preparation of phloroglucinol | AKZONA INCORPORATED (US) | 1977-11-08 | — | — | US | disclosed |
| US-4051078-A | CURING | DAINICHI-NIPPON CABLES, LTD. (JA) | 1977-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11045402-B2 | Hair cosmetic composition | CUTA, GRHPR, POLR1C | BACE1 3350/4885GABRA1 1832/4885GABRB2 1851/4885 |
| US-20210198223-A1 | METHODS AND COMPOSITIONS RELATING TO ULTRAPURE 5-(1,1-DIMETHYLHEPTYL)-RESORCINOL | CNR1, DHCR24, CNR2 | BACE1 1527/4885GABRA1 314/4885GABRB2 1051/4885 |
| US-20210163387-A1 | ONE-STEP FLOW-MEDIATED SYNTHESIS OF CANNABIDIOL (CBD) AND DERIVATIVES | CNR1, CNR2, SQLE | BACE1 703/4885GABRA1 877/4885GABRB2 1709/4885 |
| US-11858917-B2 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus | CD4, HAVCR2, CD2 | BACE1 2109/4885GABRA1 3196/4885GABRB2 2825/4885 |
| US-20220133634-A1 | SUSTAINED RELEASE SOLID DOSAGE FORMS FOR MODULATING THE COLONIC MICROBIOME | APC, SNCA, PARK7 | BACE1 154/4885GABRA1 2343/4885GABRB2 2204/4885 |
| US-11129781-B2 | Agent for hair deforming treatment | GRHPR, SLC26A4, COL1A1 | BACE1 3990/4885GABRA1 3544/4885GABRB2 3259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.